Nuzenio

Opgx

Opgx news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Analyst Reiterates Buy on Opus Genetics as Pivotal OPGx‑LCA5 Trial Advances and Cash Runway Extends Into 2028 - TipRanksTipRanks · Fri, 07 Aug 2026 09:02:30 GMTOpus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:18:54 GMTOpus Genetics Reports Q2 2026 Results and Advances Multiple IRD Gene Therapy Programs with OPGx-BEST1 Data Expected in September - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTOpus Genetics reports Q2 2026 results: $0.8M revenue, $8.1M net loss, $88.8M cash - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTOpus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:39:16 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+Eyewire+ · Tue, 04 Aug 2026 13:06:40 GMTOpus Genetics Completes Enrollment in OPGx-LCA5 Phase 3 Trial - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 07:38:27 GMTOpus Genetics enrolls last patient in OPGx-LCA5 trial - TipRanksTipRanks · Mon, 03 Aug 2026 12:21:18 GMT

Timeline

Fri, 07 Aug 2026 09:02:30 GMTAnalyst Reiterates Buy on Opus Genetics as Pivotal OPGx‑LCA5 Trial Advances and Cash Runway Extends Into 2028 - TipRanks
Thu, 06 Aug 2026 11:18:54 GMTOpus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update - The Manila Times
Thu, 06 Aug 2026 11:15:00 GMTOpus Genetics Reports Q2 2026 Results and Advances Multiple IRD Gene Therapy Programs with OPGx-BEST1 Data Expected in September - Quiver Quantitative
Thu, 06 Aug 2026 11:13:01 GMTOpus Genetics reports Q2 2026 results: $0.8M revenue, $8.1M net loss, $88.8M cash - TradingView
Wed, 05 Aug 2026 19:39:16 GMTOpus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm International
Tue, 04 Aug 2026 13:06:40 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Opgx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.